VIMPAT is indicated as: Monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 16 years and older.
Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older.